Weight loss jab users warned over rare but serious pancreas issue
Briefly

Weight loss jab users warned over rare but serious pancreas issue
"People using GLP-1 injections like Wegovy to lose weight should be aware of the rare but real chance of developing severe inflammation of the pancreas, known as acute pancreatitis. The Medicines and Healthcare products Regulatory Agency (MHRA) has said symptoms to look out for include extreme pain in the stomach and back which does not go away. It advises users of the drug to see a doctor immediately if they experience this."
"There have been hundreds of reports of acute and chronic pancreatitis from people who have taken drugs such as Mounjaro, Ozempic and Wegovy, although none are confirmed as being caused by the medicines. An estimated 1.6 million adults in England, Wales and Scotland are thought to have used drugs such as Wegovy and Mounjaro in the last year or so."
The MHRA warns people using GLP-1 injections such as Wegovy that there is a rare but real chance of developing acute pancreatitis. Symptoms include extreme, persistent stomach and back pain that may be accompanied by nausea and vomiting, and users are advised to see a doctor immediately if they experience these. Product information for professionals and patients has been updated. Hundreds of reports of acute and chronic pancreatitis have come from people taking Mounjaro, Ozempic and Wegovy, though none are confirmed as caused by the medicines. Around 1.6 million adults in England, Wales and Scotland are estimated to have used these drugs recently. Only use GLP-1 medicines if prescribed and discuss benefits and risks with a prescriber.
Read at www.bbc.com
Unable to calculate read time
[
|
]